Redispensing of unused HIV post-exposure prophylaxis for medical students

Charlotte L Bekker; Raween W Kalicharan; Eward J Melis; Helga Gardarsdottir; Bart J F van den Bemt; Marcel L Bouvy; Erik M van Maarseveen; Antoine C G Egberts

doi:10.1016/j.tmaid.2019.02.005

Redispensing of unused HIV post-exposure prophylaxis for medical students

Travel Med Infect Dis. 2019 May-Jun:29:82-83. doi: 10.1016/j.tmaid.2019.02.005. Epub 2019 Feb 25.

Authors

Charlotte L Bekker¹, Raween W Kalicharan², Eward J Melis³, Helga Gardarsdottir⁴, Bart J F van den Bemt⁵, Marcel L Bouvy⁶, Erik M van Maarseveen⁷, Antoine C G Egberts⁸

Affiliations

¹ Department of Pharmacy, Sint Maartenskliniek, Nijmegen, the Netherlands; Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: c.bekker@maartenskliniek.nl.
² Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: raween.pharma@icloud.com.
³ Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: e.j.melis-2@umcutrecht.nl.
⁴ Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland. Electronic address: h.gardarsdottir@uu.nl.
⁵ Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: b.vandenbemt@maartenskliniek.nl.
⁶ Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands. Electronic address: m.l.bouvy@uu.nl.
⁷ Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: e.m.vanmaarseveen@umcutrecht.nl.
⁸ Department of Clinical Pharmacy, Division Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands. Electronic address: a.c.g.egberts@uu.nl.

PMID: 30818013
DOI: 10.1016/j.tmaid.2019.02.005

No abstract available

Publication types

Letter

MeSH terms

Anti-HIV Agents / economics
Drug Combinations
Follow-Up Studies
HIV Infections / prevention & control*
Humans
Internship and Residency / economics
Internship and Residency / organization & administration*
Lamivudine / economics
Lopinavir / economics
Netherlands
Pharmaceutical Services / economics*
Post-Exposure Prophylaxis / economics*
Retrospective Studies
Ritonavir / economics
Zidovudine / economics

Substances

Anti-HIV Agents
Drug Combinations
lamivudine, zidovudine drug combination
lopinavir-ritonavir drug combination
Lopinavir
Lamivudine
Zidovudine
Ritonavir